Related Experiment Videos
Mechanism of ochratoxin A-induced immunosuppression
1Institute of Immunology and Rheumatology, Rikshospitalet, National Hospital, Oslo, Norway.
Abstract:
Ochratoxin A (OA) has been reported to affect immune function both at the level of antibody synthesis and natural killer (NK) cell activity. In the present study we demonstrate that exposure of purified human lymphocyte populations and subpopulations to the toxin will abrogate the cells' ability to respond to activating stimuli in vitro. Thus, both IL-2 production and IL-2 receptor expression of activated T lymphocytes are severely impaired. When the cells are preincubated with the analogue ochratoxin B (OB) prior to OA exposure, the inhibitory effect of OA is reversed. Furthermore, the inhibitory effect of OA on antibody production is not only due to blocking of T helper cell function. Highly purified B lymphocytes will not respond to polyclonal activators in vitro after a brief pulse with OA. The results strongly suggest that the toxin causes its immunosuppression through interference with essential processes in cell metabolism irrespective of lymphocyte population or subpopulation.
Insights
Ochratoxin A (OA) impairs immune cell function by affecting T and B lymphocytes. This mycotoxin inhibits antibody production and T-cell responses, suggesting a broad impact on cellular metabolism.
Area of Science:
- Immunology
- Toxicology
- Cell Biology
Background:
- Ochratoxin A (OA) is a mycotoxin known to affect immune functions, including antibody synthesis and natural killer (NK) cell activity.
- Previous studies suggest OA's impact on the immune system, but the precise mechanisms on lymphocyte subpopulations require further elucidation.
Purpose of the Study:
- To investigate the in vitro effects of Ochratoxin A (OA) on purified human lymphocyte populations and subpopulations.
- To determine the impact of OA on T lymphocyte function, including IL-2 production and IL-2 receptor expression.
- To assess the direct effect of OA on B lymphocyte responsiveness to polyclonal activators.
Main Methods:
- Exposure of purified human lymphocyte populations and subpopulations to Ochratoxin A (OA) in vitro.
- Assessment of IL-2 production and IL-2 receptor expression in activated T lymphocytes.
- Evaluation of B lymphocyte response to polyclonal activators following OA exposure.
- Preincubation with ochratoxin B (OB) to assess its effect on OA's inhibitory activity.
Main Results:
- Ochratoxin A (OA) exposure abrogated the ability of human lymphocytes to respond to activating stimuli in vitro.
- Both IL-2 production and IL-2 receptor expression of activated T lymphocytes were severely impaired by OA.
- OA directly inhibited B lymphocyte responsiveness to polyclonal activators, independent of T helper cell function.
- Preincubation with ochratoxin B (OB) reversed the inhibitory effects of OA.
Conclusions:
- Ochratoxin A (OA) exerts immunosuppressive effects through interference with essential cellular metabolic processes.
- The immunosuppression induced by OA affects both T and B lymphocyte subpopulations.
- OA's mechanism of action appears to be independent of lymphocyte population or subpopulation, indicating a fundamental cellular impact.